Welcome to CDC Stacks | Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria - 38434 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria
  • Published Date:
    Apr 2016
  • Source:
    Sex Transm Dis. 43(4):243-248.


Public Access Version Available on: April 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Pubmed ID:
    26967301
  • Pubmed Central ID:
    PMC4789762
  • Funding:
    D43 TW001041/TW/FIC NIH HHS/United States
    D43TW01041/TW/FIC NIH HHS/United States
    R01 AI120913/AI/NIAID NIH HHS/United States
    R01 MH099001/MH/NIMH NIH HHS/United States
    R01MH099001-01/MH/NIMH NIH HHS/United States
    U2G IPS000651/PHS HHS/United States
    U2G PS000651/PS/NCHHSTP CDC HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Background

    Prevalence estimates of anal high-risk human papillomavirus (HR-HPV) are needed in sub-Saharan Africa where HIV is endemic. This study evaluated anal HR-HPV in Nigeria among HIV-positive and HIV-negative men who have sex with men (MSM) for future immunization recommendations.

    Methods

    We conducted a cross-sectional study to compare the prevalence of anal HR-HPV infections between 64 HIV-negative and 90 HIV-positive MSM. Multivariate Poisson regression analyses were used to examine demographic and behavioral risk factors associated with any HR-HPV infections.

    Results

    The median age of the 154 participants was 25 years (interquartile range [IQR]: 22-28, range: 16-38) and the median age at initiation of anal sex with another man was 16 years (IQR: 13-18, range: 7-29). The prevalence of anal HR-HPV was higher among HIV-positive than HIV-negative MSM (91.1% vs. 40.6%, p<0.001). In the multivariate analysis, HIV infection (adjusted prevalence ratio [aPR]: 2.02, 95% CI: 1.49-2.72), ten years or more since anal sexual debut (aPR: 1.26, 95% CI: 1.07-1.49), and concurrent relationships with men (aPR: 1.32, 95% CI: 1.04-1.67) were associated with increased anal HR-HPV prevalence.

    Conclusions

    Anal HR-HPV infection is high for young Nigerian MSM and rates are amplified in those co-infected with HIV. Providing universal coverage as well as catchup immunization for young MSM may be an effective anal cancer prevention strategy in Nigeria.

  • Supporting Files:
    No Additional Files